View Author
blood fl ow group study hypertrophic cardiomyopathy patient control value blood method cardiomyopathy hypertrophic efficiency hcm group oxygen consumption volume tissue compartment model model control group regression k 1 values tracer correction metabolism imaging oxygen difference analysis tissue correlation coef ficients figure positron emission tomography result mvo 2 /minute correlation bland-altman plot hcm patients function 0.001 study groups relationship compartment g ötte mj consumption perfusion bland-altman effect regression analysis table image hcm groups metabolite van den hoff septum ficient 1.5 2.0 0.5 heart spillover emission cardiology tomography 0.0 1.0 correlation coef ficient time activity curve fl ow ranges septal cardiol regression line positron minute range uptake resonance imaging energetic hypertrophy timmer activity
3 Most Recent Publications
|
Did accelerated filing requirements and SOX Section 404 affect the timeliness of 10-K filings?
(Article)
Impink, J. Lubberink, M. Praag, B. van Veenman, D. |
2012-06-01
|
|
Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy
(Article)
Timmer, S.A.J. Lubberink, M. Germans, T. Götte, M.J.W. Berg, J.M. ten Cate, F.J. ten Rossum, A.C. van Lammertsma, A.A. Knaapen, P. |
2010-04-01
|
|
Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy
(Article)
Timmer, S.A.J. Germans, T. Rossum, A.C. van Götte, M.J.W. Rüssel, I.K. Dijkmans, P.A. Lubberink, M. Berg, J.M. ten Cate, F.J. ten Lammertsma, A.A. Knaapen, P. |
2010-04-01
|
